These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 20609201)
1. Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura. Ojeda-Uribe M; Federici L; Wolf M; Coppo P; Veyradier A Transfusion; 2010 Mar; 50(3):733-5. PubMed ID: 20609201 [No Abstract] [Full Text] [Related]
2. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Zaja F; Battista ML; Pirrotta MT; Palmieri S; Montagna M; Vianelli N; Marin L; Cavallin M; Bocchia M; Defina M; Ippoliti M; Ferrara F; Patriarca F; Avanzini MA; Regazzi M; Baccarani M; Isola M; Soldano F; Fanin R Haematologica; 2008 Jun; 93(6):930-3. PubMed ID: 18403395 [TBL] [Abstract][Full Text] [Related]
3. Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease. Treliński J; Chojnowski K; Kurenko-Deptuch M; Kasznicki M; Bernatowska E; Robak T Ann Hematol; 2005 Nov; 84(12):835-6. PubMed ID: 16078034 [No Abstract] [Full Text] [Related]
4. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases. Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292 [TBL] [Abstract][Full Text] [Related]
5. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]
6. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab. Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247 [TBL] [Abstract][Full Text] [Related]
7. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura. Riksen NP; Keuning JJ; Vreugdenhil G Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524 [TBL] [Abstract][Full Text] [Related]
8. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults. Provan D; Butler T; Evangelista ML; Amadori S; Newland AC; Stasi R Haematologica; 2007 Dec; 92(12):1695-8. PubMed ID: 18055995 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpura. Benetatos L; Vassou A; Bourantas KL Clin Lab Haematol; 2006 Aug; 28(4):288-9. PubMed ID: 16898975 [No Abstract] [Full Text] [Related]
10. Rituximab for the treatment of autoimmune cytopenias. Berentsen S Haematologica; 2007 Dec; 92(12):1589-96. PubMed ID: 18055980 [No Abstract] [Full Text] [Related]
11. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab. Kuwana M; Iki S; Urabe A Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment of mitomycin-induced thrombotic thrombocytopenic purpura with rituximab. Onitilo AA; Engel JM; Clouse LH; Gerndt KM J Vasc Interv Radiol; 2009 Feb; 20(2):275-6. PubMed ID: 19054690 [No Abstract] [Full Text] [Related]
13. Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura. Fianchi L; Rossi E; Murri R; De Stefano V; Pagano L; Leone G Ann Hematol; 2007 Mar; 86(3):225-6. PubMed ID: 17031685 [No Abstract] [Full Text] [Related]
14. Rituximab therapy for refractory immune thrombocytopenic purpura in elder patients. Hangaishi A; Takahashi T; Masuda A; Okada S; Kandabashi K; Kurokawa M Int J Hematol; 2010 Mar; 91(2):336-7. PubMed ID: 20063132 [No Abstract] [Full Text] [Related]